165 related articles for article (PubMed ID: 31552416)
1. Determinants of Latent Tuberculosis Treatment Acceptance and Completion in Healthcare Personnel.
Swift MD; Molella RG; Vaughn AIS; Breeher LE; Newcomb RD; Abdellatif S; Murad MH
Clin Infect Dis; 2020 Jul; 71(2):284-290. PubMed ID: 31552416
[TBL] [Abstract][Full Text] [Related]
2. Management of Latent Tuberculosis Infection Among Healthcare Workers: 10-Year Experience at a Single Center.
Arguello Perez E; Seo SK; Schneider WJ; Eisenstein C; Brown AE
Clin Infect Dis; 2017 Nov; 65(12):2105-2111. PubMed ID: 29020308
[TBL] [Abstract][Full Text] [Related]
3. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
[TBL] [Abstract][Full Text] [Related]
4. Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country.
Sullivan K; Pease C; Zwerling A; Mallick R; Van Dyk D; Mulpuru S; Allen C; Alsdurf H; Alvarez GG
BMC Public Health; 2021 May; 21(1):964. PubMed ID: 34020616
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis.
Han SS; Lee SJ; Yim JJ; Song JH; Lee EH; Kang YA
PLoS One; 2019; 14(9):e0222810. PubMed ID: 31536577
[TBL] [Abstract][Full Text] [Related]
6. Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital.
Chung SJ; Lee H; Koo GW; Min JH; Yeo Y; Park DW; Park TS; Moon JY; Kim SH; Kim TH; Sohn JW; Yoon HJ
Sci Rep; 2020 Apr; 10(1):6462. PubMed ID: 32296096
[TBL] [Abstract][Full Text] [Related]
7. Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data.
Stockbridge EL; Miller TL; Carlson EK; Ho C
BMC Public Health; 2018 May; 18(1):662. PubMed ID: 29843664
[TBL] [Abstract][Full Text] [Related]
8. Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic.
Dobler CC; Marks GB
PLoS One; 2012; 7(11):e48900. PubMed ID: 23139824
[TBL] [Abstract][Full Text] [Related]
9. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic.
Gaensbauer J; Aiona K; Haas M; Reves R; Young J; Belknap R
Pediatr Infect Dis J; 2018 Mar; 37(3):224-228. PubMed ID: 28777204
[TBL] [Abstract][Full Text] [Related]
10. Treatment guidelines for latent tuberculosis infection.
;
Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
[TBL] [Abstract][Full Text] [Related]
11. Introduction of short course treatment for latent tuberculosis infection at a primary care facility for refugees in Winnipeg, Canada: A mixed methods evaluation.
Chevrier C; Diaz MH; Rueda ZV; Balakumar S; Haworth-Brockman M; Marin DM; Oliver A; Plourde P; Keynan Y
Front Public Health; 2022; 10():1064136. PubMed ID: 36726628
[TBL] [Abstract][Full Text] [Related]
12. Identifying factors affecting latent tuberculosis treatment acceptance among healthcare workers: a retrospective analysis in a tertiary care centre.
Bar-Meir M; Pariente G; Romem A; Wiener-Well Y
BMJ Open; 2021 Sep; 11(9):e047444. PubMed ID: 34493512
[TBL] [Abstract][Full Text] [Related]
13. Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older.
Noh CS; Kim HI; Choi H; Kim Y; Kim CH; Choi JH; Hyun IG; Baek MS
Respir Med; 2019 Oct; 157():52-58. PubMed ID: 31522030
[TBL] [Abstract][Full Text] [Related]
14. Use of Rifapentine and Isoniazid Directly Observed Therapy for the Treatment of Latent Tuberculosis Infection in a Military Clinic.
Jinbo J; Lustik M; West GF; Kloetzel M
Mil Med; 2017 Sep; 182(9):e2024-e2029. PubMed ID: 28885972
[TBL] [Abstract][Full Text] [Related]
15. Latent tuberculosis infection: Opportunities and challenges.
Chee CBE; Reves R; Zhang Y; Belknap R
Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
[TBL] [Abstract][Full Text] [Related]
16. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
[TBL] [Abstract][Full Text] [Related]
18. Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.
Huang YW; Yang SF; Yeh YP; Tsao TC; Tsao SM
Medicine (Baltimore); 2016 Aug; 95(34):e4126. PubMed ID: 27559940
[TBL] [Abstract][Full Text] [Related]
19. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE
JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332
[TBL] [Abstract][Full Text] [Related]
20. [10 years of innovation in the treatment of latent tuberculosis infection: a comparison between standard and short course therapies in directly observed therapy].
López G; Wood M; Ayesta FJ
Rev Esp Sanid Penit; 2011; 13(1):3-14. PubMed ID: 21484073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
